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Background: Weaning of patients from mechanical cardiac support after myocardial
recovery has always involved multiple, interacting factors, particularly the training
of the myocardium during reduction of pump flow. Rotary pumps offer training
advantages when support flow is reduced, even to nearly zero. We report a computer
analysis that evaluates the work required of the heart during partial unloading and
removal of rotary pumps.
Methods and Results: A computer model of the assisted circulation, previously
implemented in MATLAB (The MathWorks Inc, Natick, Mass), has been aug-
mented with a model of the MicroMed DeBakey ventricular assist device (Mi-
croMed Technology, Inc, Houston, Tex). Flow, pressure patterns, and external work
(pressure-volume area, calculated as the area of the ventricular pressure-volume
loop [external work] plus potential energy) were calculated for nonassisted and
various continuously assisted patients. Under low-flow conditions, the heart imposes
an oscillating forward–backward flow through the non-occlusive rotary pump,
causing an increase in ventricular work. Thus, an assist flow of 1 to 1.5 L/min
requires work equivalent to that of the unsupported heart. At 60% contractility, the
nonassisted pressure-volume area is 1.10 Ws/beat, and the potential energy is 0.38
Ws/beat. At a Qpump of 1 L/min, the pressure-volume area is 1.21 Ws/beat, and the
potential energy is 0.37 Ws/beat. At a Qpump of 3 L/min, the pressure-volume area
is 0.93 Ws/beat, and the potential energy is 0.29 Ws/beat. These conditions cannot
be achieved with pulsatile systems.
Conclusion: During weaning and retraining, an implanted rotary pump can provide
a workload to the heart like that in the nonassisted situation, thus increasing the
predictability of weaning and reducing the risk of reiterating heart failure.
Bridging the failing heart to myocardial recovery has always been akey indication for the application of mechanical cardiac assistdevices and has become more relevant with the shortage of donorgrafts for transplantation in recent years. Various reasons for car-diac failure, including acute inflammation, autoimmune disease,and long-term cellular degradation suggest different therapeutic
approaches,1-4 but the number of successful withdrawals is still low. New options
such as stem cell therapy and the use of neoangiogenic agents may increase the
number of successful withdrawals.5-7
However, the determination of when to withdraw assistance and explant the
assist device has always been crucial. From the standpoint of myocardial retraining
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and reliable evaluation of myocardial capacity, driving the
pump at low—or even zero—flow would be highly desir-
able. However, in pulsatile systems, a flow less than ap-
proximately 3 L/min is correlated with a greatly increased
risk of thrombus formation, and a flow near zero is abso-
lutely prohibited for times exceeding several minutes. So-
phisticated protocols and diagnostic parameters have there-
fore been developed to assess recovered heart function
during short interruptions of assist to evaluate the possibility
of weaning.1,3,8 With the paracorporeal rotary blood pumps
now widely used, along with their long tubes, a flow less
than 1.5 L/min for extended time periods is likely to raise
the risk of embolization because of extended particle resi-
dence time and reduced washout.
In contrast with these devices, implanted axial pumps,
because of their design and shorter cannulas, have less
blood-contacting surface and fewer stagnation points. Be-
cause of lower hydraulic inertia and friction loss in these
short cannulas, blood flow acquires a greater pulsatile com-
ponent after initial cardiac recovery.9,10 In the case of pump
stoppage, the natural heart generates a leakage flow through
the pump that is equivalent to a medium-grade aortic insuf-
ficiency. One group even suggests that it is possible to stop
the device for extended time periods,11,12 although the po-
tential thrombogenicity of a stationary mechanical bearing
has not been examined in detail.
The features of axial pumps allow reducing pump flow
for extended times and therefore make them excellent can-
didates for patients who appear capable of ventricular re-
covery and weaning. As mentioned previously, the number
of such patients may substantially increase when new ther-
apies aiding recovery after massive myocardial infarction
become available.
However, if such pumps are adjusted to low rotational
speeds and mean flows near zero, forward–backward flow
pulsations through the pump will cause considerable posi-
tive and negative instantaneous values of flow. Consistent
with these observations, some currently available control-
lers do not allow speed to be adjusted below a set level for
reasons of safety. These flow conditions are already some-
what equivalent to aortic valve insufficiency, because they
require the heart to eject an additional volume during sys-
tole that is returned by backflow through the pump during
diastole. Thus, a mean flow of zero is not equivalent in an
unassisted patient as it would be in a patient with a pulsatile,
valved assist device, in which pump stoppage causes valve
closure.
Thus we hypothesized, for a patient assisted with a rotary
pump, that a flow considerably greater than zero would
already approximate the nonassisted case with respect to
cardiac work and energetics. This hypothesis was addressed
within our previously established and described computer
model. This model also permits calculation of pressure-
volume (PV) loops and the energetic parameters: external
work (EW), potential energy (PE), and cumulative PV area
(PVA). These, then, represent the metabolic demand of
pumping13-15 (Figure 1).
In this study, the unloading and loading effects of im-
planted axial pumps were calculated under weaning condi-
tions and compared with both paracorporeal rotary blood
pumps and pulsatile assist devices.
Methods
A computer model of the cardiovascular system was developed
and parameterized with data obtained from the literature, and in
vitro, in vivo, and clinical data were obtained by the authors as
described in detail elsewhere.13 Automatic parameter variations
with feedback loops (keeping selected parameters such as arterial
pressure constant) and under varying states of contractility were
performed.
Necessary data describing pump and cannula performance were
obtained in a hydrodynamic mock loop of Donovan-Design,16 with
pressure (Hellige, Freiburg, Germany) and flow (Transonic Inc,
Ithaca, NY) monitoring.
Three sets of pump–cannula equations, corresponding to 3
alternative systems, were used in the current study (Figure 2). (1)
Implanted rotary pump: These equations represented the hydrome-
chanical situation imposed by a fully implanted DeBakey ventric-
ular assist device (MicroMed Technology, Inc, Houston, Tex). The
pump was positioned with a 15-cm apical inflow cannula from the
left ventricle and a 30-cm outflow cannula to the ascending aorta.
(2) Paracorporeally positioned rotary pump: These equations rep-
resented the hydrodynamic effect of a paracorporeally placed
pump with two 38-inch tubes, each 1 m in length. (3) Pulsatile
implanted system: These equations represented the hydrodynamic
effect of a Novacor-Cardiac Assist Device (World Heart Inc,
Ottawa, Canada) implanted abdominally with a 9-cm proprietary
inflow cannula and a 30-cm outflow graft.
For this study, the model structure was simplified to focus on
the interaction between the left ventricle and the pump (Figure 2).
The following parameters were selected to mimic the typical
condition of a clinical candidate for weaning. The peripheral
resistance was adjusted to provide a constant aortic pressure of 85
mm Hg at a systemic flow (pump flow plus cardiac flow) of 5
L/min, independent of the central venous pressure. The systemic
flow of 5 L/min was achieved by variation of venous return
through pulmonary venous pressure, mimicking the clinically mo-
tivated goal of keeping the cardiac index within normal ranges.
The contractility of the left ventricle was assumed to be 50%, 60%,
70%, 80%, or 100% of normal contractility, equivalent to ejection
fractions of 34%, 44%, 50%, 54%, and 58%. These values corre-
spond to typical ejection fractions of candidates for weaning. The
heart rate was kept constant at 80 beats/min.
The rotary pumps were driven at constant speed to achieve the
desired levels of assist flow (0-5 L/min, corresponding to 0%-
100%, in 6 steps). Pulsatile pumps were not in detail part of this
study, because of their large variability in frequency, systolic time,
phase, driving force, and synchronization. Therefore, for compar-
ison, only a typical pulsatile setting for minimal allowable support
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at normal anticoagulation was included in this study, with a 1:2
support mode at a pump rate of 40 beats/min.
The following parameters were calculated:17 EW of the left
ventricle, which corresponds to the area within the PV loop; PE,
which is defined as the area within the trace of end-systolic PV
relation; end-diastolic PV relation of the PV loop; and cumulative
PVA PE EW, which is considered to correspond to the whole
consumption of metabolic energy per heartbeat.
Results
Figures 1, 3, and 4 show examples of flow and pressure
patterns of an assisted patient with an implanted axial pump
working at 3 levels (0, 1.8, and 4.6 L/min). The waviness in
pump flow caused by the cardiac contractility, the mitral
flow pattern influenced by atrial contractility, and the re-
duced pulsatility in ventricular and aortic pressure, com-
pared with healthy subjects, can all be seen. The slight
inclinations of the PV loop during so-called isovolumetric
contraction and relaxation show that these phases of the
cardiac cycle are not in fact isovolumetric because of the
pump flow.
Figure 5 gives the EW, PE, and resulting PVA without
pump; the stopped pump with backflow; and various assist
levels with a mean pump flow between 0 and 5 L/min. As
hypothesized, a mean level of pump flow of zero imposes a
greater load on the heart than the occluded condition. In
fact, the occluded condition is equivalent, under these con-
ditions, to a support level of approximately 1.5 to 1.8 L/min
of forward flow.
Figure 6 shows the effect of a paracorporeally placed
pump and its 2 meters of tubing and cannula. Because of
inertia and friction, the flow waviness is far lower than for
the implanted system. Therefore there is practically no
pendular volume load on the ventricle, and the loading
conditions compared with the case without pump are very
similar to a mean flow of zero (Figures 1 and 6). Of course,
in this situation an unoccluded, stopped pump would in-
crease cardiac load because of backflow.
Further, we tested whether changes in contractility af-
fected the level of support flow at which the load on the
heart was equal to that with no support. Within a contrac-
tility range of 60% to 80%, which corresponds to an ejection
fraction between 44% and 54% in the unassisted heart, no
major shift of this clamp-equivalent flow was observed.
This observation shows that 1.5 to 1.8 L/min of forward
Figure 1. Comparison of flow patterns and pressure-volume (PV) loops of the unassisted left ventricle with left
ventricular assistance by implanted and paracorporeally placed rotary pumps at a mean flow of 0 L/min. Compared
with the unassisted heart, the flow pattern and PV loops for an implanted pump with short cannulas considerably
increases the area of the PV loop because of pendulular flow. The paracorporeally positioned pump with long
cannulas provides a load to the heart similar to that in the unassisted case. EW, External work; PE, potential
energy; PVA, pressure-volume area; Qavo, flow through the aortic valve orifice; Qpump, flow through the pump; Qmvo,
flow through the mitral valve orifice.
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flow at an overall cardiac output of 5 L/min (ie, 30% of
total flow from the pump) would give the heart a load
equivalent to an occluded system.
Even at a contractility of 50% (33% ejection fraction
without assistance), the ventricle shows a strongly reduced
capability to unload the atrium, leading to atrial pressures of
more than 15 mm Hg.
In Figure 7, the condition for a pulsatile assist system is
shown for a 1:1 unloading mode (ie, every second beat is
assisted) at weaning. The complexity of such an unloading
Figure 2. Model structure used for simulation.
Figure 3. Pressure and flow patterns and PV loop for full assist by the implanted pump (heart rate 80 beats/min,
contractility 60%, pump flow 4.6 L/min). ESV, End-systolic volume; EDV, end-diastolic volume; LVP, left ventricular
pressure; AOP, aortic pressure; LAP, left atrial pressure.
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pattern can be seen in the PV loop. In comparison with
rotary pumps, every second beat would be massively
unloaded (corresponding to full unloading with a rotary
pump) and the intervening beat would be far less loaded
than without a pump because of the reduced mean atrial
pressure.
Discussion
During the last 4 years, continuous flow pumps have proven
their ability to provide full restoration of organ function in
patients with terminal heart failure and to sustain support for
extended time periods.9,11,18-21 These systems are already a
real alternative to pulsatile devices, offering a number of
advantages concerning size, blood-contacting surface, sim-
plicity, lack of venting tubes (and therefore the ability to use
more flexible cables), and far fewer infections in the expe-
rience of our center. (As of April 2003, 15 patients have left
the hospital while supported, 14 have undergone transplan-
tation, 2 currently remain on support in the hospital, and 10
have died.)
Figure 4. Pressure and flow patterns and PV loop for a mean flow of 1.8 L/min through the implanted pump (point
of load equivalent to occluded pump). The pump flow pattern Qpump includes a considerable backflow during
diastole.
Figure 5. EW, PE, and PVA for implanted rotary pump at occlusion, zero speed, and various levels of pump flow
from 0% to 100% (ie, 0-5 L/min) The PVA at pump support decreases with increasing pump flow, but because of the
pendulum volume, the effect of pump removal on PVA is equivalent to the PVA at 1.8 L/min positive mean flow.
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Non-occlusiveness has been discussed intensively be-
cause of the safety threat it poses in case of pump stop-
page.22,23 Certainly, backflow imposes an increased volume
load on the left ventricle, typically in the range of 1 to 2
L/min (mean value) with an implanted pump. This load is
similar to that imposed by a moderate grade of insufficiency
in the aortic valve.24 On the other hand, backflow offers the
advantage of washout and avoidance of thrombus growth,
effects that increase the time for reaction to pump stoppage
if the heart has sufficiently recovered to withstand the
unassisted period.11
In addition, an unobstructed flow path provides new
approaches to weaning in case of cardiac recovery, allowing
reduction of support to very low or even negative values.
This approach is impossible with pulsatile pumps, in which
flow less than 2.5 to 2 L/min would lead to thrombus
formation. Sophisticated protocols have been developed for
weaning patients from pulsatile devices.1-4 The procedure
Figure 6. EW, PE, and PVA for paracorporeally placed rotary pump with long inflow and outflow cannulas (both
1 m). Because of the lower pendulum volume resulting from the damping effect of the tubing, the PVA without pump
is equivalent to the situation at zero flow through the paracorporeal pump.
Figure 7. Pressure and flow patterns and PV loops for a pulsatile assist device in 1:1 assist mode (resulting mean
pump flow 2.55 L/min). The pump supports every second heart beat, leading to a complex shape of the PV loop.
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usually involves several steps of flow reduction, using in-
creasing anticoagulation, with initial stoppage occurring
during several minutes under catheterization, echo control,
or both. However, because the heart cannot be trained at
minimal support values for extended time periods, the de-
cision to explant these devices is very difficult because the
process immediately subjects the heart to a considerable
additional load.25
With rotary pumps, flow can be reduced to minimal
values, imposing only the risk of multiple reiterating pas-
sages of pendular flow through the pump, which may in-
crease hemolysis. However, as demonstrated in this article,
a mean flow of zero is not equivalent to a removed or
occluded pump. Although this pendular blood volume does
not create any hydraulic energy in the arterial system (ex-
cept viscous losses), it does create additional area in the PV
loop and therefore increases metabolic demand.
For weaning purposes, it would be interesting to know
the pump speed and corresponding level of flow support that
would be equivalent to the situation after pump removal.
The simulation presented in this article predicts that a sup-
port level of approximately 30% of the whole cardiac out-
put, with the pump in place, would be equivalent to the
workload after explant. Mean rotary pump flows less than
1.5 L/min (in an average adult equivalent to 25% of
normal cardiac output) would train a patient’s heart to a
situation exceeding that imposed by pump removal.
This numeric result clearly requires testing in vivo even
though it is based on the well-accepted theory of PV loops,
which states the PVA to be equivalent to metabolic de-
mand.14,15 The unusual situation of continuous unloading,
paradoxic effects to the right ventricle because of septal
movements, and inaccuracies in the definition of PVA in the
case of decompensating ventricles with nonlinear end-sys-
tolic pressure relationships13 may all influence the actual
result. Notwithstanding these concerns, this study clearly
predicts that implanted rotary pumps with short cannulas
provide a far better transition to full ventricular load than
either paracorporeally placed pumps with long cannulas or
pulsatile pumps.26 The latter require minimal flow to pre-
vent thromboembolism and provide variable unloading
from beat to beat. Rotary pumps also permit anticipating,
for extended time periods, the increased load the heart will
experience after explant. This feature may be important in
choosing pumps intended for temporary assist in combina-
tion with other adjuvant therapies. This study does not
account for changing conditions in the right ventricle, which
is certainly influenced, at least, by the changing load on the
intraventricular septum.
On the other hand, this study suggests that pulsatile
pumps have a greater potential for ventricular unloading
from the metabolic viewpoint. Pulsatile assist might be
preferred when partial assistance is needed in the early
postoperative period. However, in this situation the pump
usually carries the full flow and the aortic valve stays
closed. Nonetheless, pulsatility could be desirable when the
aortic valve opens after initial recovery.
Of course, this computer study also contains some inher-
ent limitations: The heart was modeled without additional
comorbidities, especially disturbances in diastolic relax-
ation or valve insufficency, which may well occur in recov-
ering hearts. Such deficiencies may influence the quantita-
tive results but should not alter the general trends. Further,
it has not yet been proven that axial pumps can be run at low
flows without increase of thromboembolic risk, but the
experiences with extended switch-off of pumps and the
recent application of a MicroMed DeBakey ventricular as-
sist device in a child cause optimism for a proper perfor-
mance of these pumps also at low-flow rates.
Conclusion
Unloading of the native ventricle by implanted rotary
pumps is influenced by an oscillating flow caused by inter-
action between the pump and ventricle. This flow imposes
an additional metabolic demand that can be evaluated from
changes in the area under a PV curve. The additional load
cancels the benefit of pump support to the heart at ratios of
pump flow to systemic flow of 25% to 30%. This effect
suggests effective means of weaning the heart from support
before pump removal.
We thank Professor Edward Leonard of Columbia University,
currently a Fulbright Guest Professor at our institution, for contri-
butions to the discussion of this work.
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